Skip to main content
. Author manuscript; available in PMC: 2022 Jan 10.
Published in final edited form as: Neurosci Lett. 2020 Nov 14;741:135502. doi: 10.1016/j.neulet.2020.135502

Fig. 1.

Fig. 1.

Experimental timeline. For 2 weeks, Tat+ and Tat transgenic mice in cohort 1 were administered doxycycline (DOX) supplemented chow to induce Tat expression. Starting on day 1 of DOX administration, cohort 1 mice were repeatedly injected with escalating doses of morphine (10 – 40 mg/kg, s.c., that was increased by 10 mg/kg increments at 2 day intervals) or saline (b.i.d.) for 2 weeks and the brains were harvested for immunohistochemistry. Cohort 2 mice received DOX for 4 weeks. During the final 2 weeks of DOX administration, starting on day 14, mice were additionally injected with the same escalating morphine dosing paradigm as in cohort 1. Mice were humanely euthanized, and the PFC, striatum, and hippocampus were dissected for immunoblotting.